In September 2011, Agency for Science, Technology and Research, Biomedical Research Council (A*STAR) and National Health and Medical Research Council, (NHMRC) signed a Memorandum of Understanding (MoU) of general cooperation to promote and encourage research and development activities amongst researchers from Singapore and Australia.
For the purpose of this joint grant call, emerging infectious diseases as defined by the World Health Organization as diseases that are newly recognised, newly evolved or occurred previously but have shown an increase in incidence or expansion of geographical, vector or host range, and include pathogens showing drug resistance within this definition. Integrative technology is an area of health and medical research that is rapidly expanding and includes bioinformatics, genomics (computational genomics, evolutionary genomics, functional genomics) and proteomics.
A*STAR and NHMRC wish to jointly support research proposals that utilise integrative technology to:
improve surveillance and detection of emerging infectious disease threats in our region;
advance diagnostic tools;
develop new innovative approaches for vaccine creation and therapeutics, and
bring together synergistic collaborations and expertise from both countries.
Please refer to the A*STAR website or guidelines for more details.
The maximum funding quantum for each project:
Research conducted in Singapore will be funded by A*STAR and research conducted in Australia will be funded by NHMRC.
- For Singapore Researchers: Only Singapore-based researchers from all public institutions in Singapore, including restructured hospitals, national centres, research institutes, local universities and A*STAR research institutes/consortia are eligible to apply for this collaborative grant.
- For Australian Researchers: Applications must be certified and submitted through the RAO of a registered NHMRC Administering Institution. Prospective applicants and institutions should refer to the NHMRC Administering Institutions Policy at: http://www.nhmrc.gov.au/grants/policy/admininst.htm.
- The Australian Principal Investigator can only be the Chief Investigator A (CIA) on ONE application.
- Proposals must involve a genuine collaboration involving at least one research team each from Singapore and Australia.
- Address a health area of high priority for Singapore and Australia.
- Involve hypothesis-driven research that will lead to specific, measurable outcomes for Singapore and Australia within a defined timeframe.
- Demonstrate that the research and expected outcomes could not be done without the joint input of teams from Singapore and Australia for the full term of the project
The proposals would be assessed based on:
Scientific quality of the project including feasibility (50%)
Proposal fits well within the aim and scientific remit set out in the joint grant call. Strong scientific rationale for pursuing the questions or gaps in knowledge that are being addressed. Applicants are proposing original research.
Significance of the expected outcomes OR innovative of the concept (25%)
Success is likely to lead to significant new knowledge. The application of new ideas, procedures and technologies will have impact on human health. The outcomes from the international partnership will be significant to both Singapore and Australia.
Track record of the team (relative to opportunity). This will be an indication of the teams’ ability to undertake research and deliver outcomes of benefits to both Singapore and Australia (25%)
The applicants’ previous research demonstrates that the research team is capable of achieving the proposed project. Team members have established a high quality track record relevant to this field of research. The collaboration between Singaporean and Australian researchers is synergistic and beneficial to both Singapore and Australia.
a) Online application – All applications must be submitted via the NHMRC Research Grants Management System (RGMS) by the Australian Co-PI. Deadline: Wednesday – 8 August 2012 (3pm, Singapore Standard Time)
- Applicants who are not yet registered on RGMS should contact the Research Help Centre on email@example.com for more information and/or read the following: Link on How to Access RGMS Instructions.
- As this joint grant call is utilising NHMRC RGMS, the Australian Co-PI, and Administering Institution will need to be Australian. [This is for administrative purposes only.] We request that the Australian Investigator register as CIA and submit the proposal on behalf of the team.
A complete application consists of:
Ø Parts A and B of the application form.
Ø The relevant information in your RGMS Profile and CV.
Ø The uploaded PDF document containing your Detailed Background and Research Plan, including Track Record for each team member and Singaporean budget request.
Ø Applicants will be required to submit two budgets with their proposals, a Singapore and an Australian budget. It is expected that the two budgets will seek a similar level of funding to support the Singapore-based research expenses and the Australian-based research expenses.
b) A PDF copy has to be forwarded to A-STAR_NHMRC@a-star.edu.sg before the closing date.
c) Please forward the following documents to NUHS Research Office – Deadline: Friday – 3 August 2012.
If the proposed study would requires biospecimen or tissue banking, please contact Dr Eng Chon Boon (firstname.lastname@example.org ) from the NUHS Tissue Repository. The tissue repository will assist in biobanking budgetary. Kindly visit http://medicine.nus.edu.sg/tissue/Cost%20Recovery%20Schedule.pdf
Please contact the following staff if you have any enquiries: